Company / Current Assets
Processa Pharmaceuticals, Inc. Current Assets History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$8.4M
FY2022
5-year range
$3.2K / $18.3M
FY2018-FY2022
Trend
-54.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3,237 to $8M over the past 6 years.
Based on SEC 10-K filings.
$8M in FY2022.
Improved from $3,237 to $8M over the past 6 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current assets decreased 54.2% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $8.4M | -54.2% |
| FY2021 | $18.3M | +566077.0% |
| FY2016 | $3.2K | -96.9% |
| FY2015 | $104.2K | -72.5% |
| FY2014 | $379.2K | -26.3% |
| FY2013 | $514.7K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026